Kim, Ki-Yoon
Hwang, Jawon
Park, Sung Hyun
Cho, Minah
Kim, Yoo Min
Kim, Hyoung-Il
Hyung, Woo Jin https://orcid.org/0000-0002-8593-9214
Funding for this research was provided by:
GC Biopharma Corporation
Investigator Sponsored Research Program (ISR-2017-10924)
Covidien Private Limited
Article History
Received: 2 September 2025
Accepted: 31 December 2025
First Online: 20 January 2026
Disclosure
: Woo Jin Hyung received research grants from Medtronic and GC Biopharma Corporation and is a stockholder and chief executive officer of Hutom. He provided consultancy services to Ethicon and SK Hynix(Wuxi) outside the submitted work. The remaining authors have no conflicts of interest.